≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of endometrium

DOID Endpoint Browser

CD2_INSITU_ENDOMETRIUM

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07.0&
  • Hospital discharge: ICD-9 — 2332
  • Cause of death: ICD-10 — D07.0&
  • Cause of death: ICD-9 — 2332

2 out of 7 registries used, show all original rules.

157

4. Check minimum number of events

None

157

5. Include endpoints

None

157

6. Filter based on genotype QC (FinnGen only)

157

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D07
Name in latin
Carcinoma in situ endometrii (corporis uteri)

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 157 157 -
Unadjusted period prevalence (%) 0.05 0.05 -
Median age at first event (years) 62.28 62.28 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
140
Matched controls
1399
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
+∞
199.1
139
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
75.9
63.4
70
18
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
62.0
63.3
73
24
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
33.0
61.1
86
64
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
192.0
50.7
50
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
59.8
46.1
53
14
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
79.8
32.9
36
6
N95.0
ICD-10 Finland
Postmenopausal bleeding
9.2
26.8
65
120
ZXC96
NOMESCO Finland
Robot assisted procedure
43.2
23.1
28
8
B01AB10
ATC
tinzaparin; parenteral
10.2
20.5
43
58
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
11.6
20.2
39
45
N84.0
ICD-10 Finland
Polyp of corpus uteri
8.0
19.6
49
88
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
27.2
15.6
21
9
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
6.1
11.6
33
67
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
38.5
11.5
14
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
22.3
11.4
16
8
JN4BD
NOMESCO Finland
Extensive body CT
5.0
10.8
37
94
B01AB05
ATC
enoxaparin; parenteral
3.4
10.5
70
318
SPAT1312
SPAT
General health counselling
3.2
9.6
72
348
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
39.5
9.2
11
*
LCA06
NOMESCO Finland
Biopsy of endometrium
3.9
9.1
41
134
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
53.4
8.8
10
*
SPAT1301
SPAT
No procedures
3.0
8.5
67
327
SPAT1249
SPAT
Treatment-related counselling outside office
2.9
8.3
79
435
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
4.6
7.7
27
69
ULC02
NOMESCO Finland
Hysteroscopy
5.1
7.6
24
55
SPAT1153
SPAT
Removal of sutures
2.8
7.4
64
326
WF090
NOMESCO Finland
Profylactic radiotherapy
42.2
6.8
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
6.7
62
324
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
4.7
6.7
22
53
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.1
6.7
26
74
-
ICD-10 Finland
NA
10.8
6.7
12
12
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
11.8
6.4
11
10
ZXE00
NOMESCO Finland
One hour or less
0.3
6.4
16
427
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.7
6.3
17
33
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.8
6.2
20
47
WX408
NOMESCO Finland
General anesthesy, balanced
0.1
6.2
*
240

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
104
177
15.44
69.21
9.9
6.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
74
123
10.49
47.79
4.3
3.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
39
41
12.33
34.78
3.2
4.7
mmol/l
3.8
3.8
0.10
39
35
(3020891) Body temperature
41
47
11.45
34.42
3.3
4.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
110
371
7.56
33.94
5.6
4.6
estimate
0.0
0.0
0.00
16
133
(3011397) Hemoglobin [Presence] in Urine by Test strip
100
331
6.57
30.72
6.0
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
58
128
6.60
27.23
1.4
2.2
g/l
0.2
0.2
2.60
58
121
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
53
120
6.16
23.94
2.1
2.9
ml/min/173m2
62.3
61.2
0.08
26
45
(3008152) Bicarbonate [Moles/volume] in Arterial blood
43
85
6.59
22.22
5.7
7.9
mmol/l
24.6
25.7
1.37
43
79
(3014007) Fractional oxyhemoglobin in Arterial blood
39
70
7.08
22.13
3.2
7.7
%
95.0
94.8
0.18
39
70
(3019060) Gas panel - Arterial blood
44
91
6.33
21.68
3.0
5.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
113
536
4.95
19.63
5.9
4.4
—
—
—
0
0
(3015736) pH of Urine
109
540
4.33
16.93
6.1
4.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
44
123
4.58
14.98
3.1
6.9
g/l
123.7
119.4
0.67
44
118
(3009261) Glucose [Presence] in Urine by Test strip
124
708
4.57
14.97
5.8
4.2
estimate
0.0
0.0
0.50
16
126
(3035350) Ketones [Presence] in Urine by Test strip
122
698
4.35
14.45
5.9
4.1
estimate
0.0
0.0
0.00
16
131
(3021601) Nitrite [Presence] in Urine by Test strip
121
704
4.13
13.61
6.4
5.6
estimate
0.0
0.0
0.00
13
127
(3027801) Oxygen [Partial pressure] in Arterial blood
46
149
3.95
12.69
3.2
6.4
kpa
13.3
12.5
0.41
46
143
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
46
149
3.95
12.69
3.2
6.4
kpa
5.2
5.3
0.11
46
143
(3016502) Oxygen saturation in Arterial blood
43
133
4.08
12.64
3.2
6.5
%
97.8
96.3
2.98
43
125
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
116
679
3.71
12.41
4.5
3.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
153
3.84
12.17
3.1
6.3
mmol/l
1.3
1.8
0.77
34
128
(3024561) Albumin [Mass/volume] in Serum or Plasma
106
623
3.16
10.53
3.4
3.7
g/l
37.1
35.5
3.10
98
578
(3014576) Chloride [Moles/volume] in Serum or Plasma
44
158
3.48
10.23
3.5
5.5
mmol/l
104.2
103.4
0.61
44
151
(3007853) Bacteria identified in Skin by Aerobe culture
38
132
3.48
9.23
2.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
307
2.61
7.49
1.4
1.4
—
—
—
0
0
(4034850)
17
38
4.90
7.38
22.1
8.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
12
432
0.22
7.02
4.1
5.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
50
4.19
6.76
1.5
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
132
995
3.05
6.48
5.4
3.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
76
488
2.08
4.82
3.0
2.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
87
1131
0.48
4.70
10.2
17.4
%
14.3
13.7
2.10
82
1111
(3031040) Bacteria [#/volume] in Urine by Automated count
123
978
2.19
4.02
5.4
4.9
—
69.1
—
0
14
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
76
520
1.89
3.76
4.8
3.5
ng/l
18.5
32.4
0.83
55
365
(40758558) Short blood count panel - Blood
58
369
1.91
3.54
5.5
7.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
56
360
1.86
3.27
1.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
102
1208
0.56
2.93
8.1
15.3
%
41.2
39.0
3.05
36
833
(40768804) Tissue Pathology biopsy report
80
589
1.73
2.88
2.3
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
22
407
0.47
2.86
1.5
1.6
mmol/l
1.6
1.3
0.51
17
335
(40761511) CBC panel - Blood by Automated count
152
1403
3.62
2.74
14.5
13.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
131
1122
2.01
2.73
5.5
4.4
pmol/l
15.4
14.9
1.65
122
1017
(3002582) Erythrocytes [#/volume] in Urine
23
411
0.48
2.68
2.3
3.1
e6/l
22.0
31.4
0.40
18
315
(40760892) CBC W Ordered Manual Differential panel - Blood
49
320
1.77
2.65
4.2
4.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
86
663
1.66
2.48
3.5
4.8
mmol/l
1.2
1.2
6.52
77
592
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
98
2.19
2.44
1.3
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
30
173
1.91
2.39
69.0
18.5
—
1.3
—
0
29
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
9
5.69
2.23
2.8
3.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
9
5.69
2.23
4.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
31
3.02
2.11
1.8
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
57
2.40
2.04
1.8
3.6
%
48.9
46.2
0.12
13
57
(3013512) EKG study
27
422
0.57
1.96
4.1
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
167
0.39
1.93
1.4
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
538
1.54
1.90
3.5
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
97
801
1.55
1.89
4.0
4.2
mmol/l
6.8
6.6
0.52
92
744
(3033658) Prothrombin time (PT) actual/Normal
20
336
0.54
1.85
1.9
3.2
%
85.5
95.3
0.69
20
325
(3012516) Albumin [Mass/volume] in Urine
56
412
1.56
1.83
2.9
2.9
mg/l
25.9
206.2
0.51
34
232
(3018095) Leukocytes [#/volume] in Urine
35
500
0.61
1.76
2.4
3.7
e6/l
20.0
113.8
3.26
27
348
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
47
0.00
1.74
0.0
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
146
1349
2.17
1.73
15.8
13.9
mg/l
26.3
21.4
0.66
123
1048
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
49
0.00
1.72
0.0
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
29
429
0.60
1.67
2.9
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
25
382
0.59
1.63
3.8
3.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
30
437
0.61
1.61
2.1
2.9
u/l
28.6
28.4
0.03
25
418
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
20
322
0.57
1.58
1.3
1.2
u/ml
0.7
1.5
—
9
87
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
151
0.44
1.53
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
338
1.51
1.48
1.9
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
55
421
1.47
1.45
2.8
2.8
mmol/l
7.0
6.3
0.70
49
332
(3013650) Neutrophils [#/volume] in Blood by Automated count
96
817
1.45
1.44
6.6
8.9
e9/l
4.1
4.0
0.16
89
717
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
40
2.32
1.42
2.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
57
441
1.46
1.42
3.4
3.6
mg/mmol
7.0
5.6
0.09
35
240
(3020564) Creatinine [Moles/volume] in Serum or Plasma
150
1424
2.20
1.41
18.0
16.4
umol/l
71.2
69.8
0.29
150
1424
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
0
38
0.00
1.36
0.0
3.5
—
24.2
—
0
31
(3034860) Kappa light chains.free [Mass/volume] in Serum
0
38
0.00
1.36
0.0
3.5
—
35.0
—
0
31
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
39
0.00
1.36
0.0
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
138
1273
1.69
1.34
4.6
4.1
mmol/l
1.4
1.2
1.37
125
1148
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
72
856
0.71
1.33
2.4
2.9
u/l
50.0
44.8
0.20
65
784
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1346
1.84
1.30
5.4
4.7
mmol/l
6.2
5.9
2.85
136
1234
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
140
1.66
1.29
1.3
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
86
727
1.40
1.28
3.8
5.6
mmol/l
1.2
1.2
6.36
74
614
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
139
1288
1.69
1.28
6.6
5.8
mmol/mol
41.1
39.6
1.03
130
1187
(4010399)
18
110
1.72
1.21
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
146
1376
1.87
1.19
5.7
5.2
mmol/l
2.9
2.8
0.32
134
1258
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
20
2.55
1.16
1.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
41
2.00
1.10
2.9
2.9
—
—
—
0
0
(4281824)
5
22
2.31
1.04
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
315
1.41
1.03
1.5
1.6
mg/l
0.7
1.0
1.08
31
241
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
92
1.70
1.01
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
52
631
0.74
1.00
2.2
2.3
nmol/l
78.2
80.4
0.25
47
551
(3024928) Oxygen saturation in Venous blood
0
29
0.00
0.99
0.0
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
30
0.00
0.98
0.0
3.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
30
0.00
0.98
0.0
1.6
—
1.3
—
0
23
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
62
1.83
0.97
1.5
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
62
1.83
0.97
1.6
2.3
%
1.3
1.1
0.41
11
62
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
51
1.81
0.96
1.7
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
28
203
1.46
0.96
1.5
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
126
0.53
0.93
3.9
3.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
142
1348
1.56
0.85
5.1
4.6
mmol/l
4.8
4.8
0.24
131
1235
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
138
1305
1.47
0.81
6.4
5.4
mu/l
2.7
1.9
0.85
129
1189
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
24
0.00
0.80
0.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
25
0.00
0.80
0.0
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
25
0.00
0.80
0.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
26
0.00
0.79
0.0
2.3
—
5.4
—
0
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
26
0.00
0.79
0.0
2.9
—
63.6
—
0
26
(3050129) First trimester maternal screen panel - Serum or Plasma
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
624
0.77
0.78
1.9
2.0
pmol/l
95.2
100.5
0.48
37
274
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
117
1081
1.32
0.77
5.3
7.2
u/l
80.2
78.0
0.18
111
992
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
34
1.79
0.77
2.3
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
57
1.61
0.72
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
57
1.61
0.72
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
58
1.58
0.71
1.3
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
41
335
1.30
0.70
3.3
3.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
78
1.58
0.67
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
764
0.81
0.63
2.4
2.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
63
1.63
0.63
1.6
3.2
mmol/l
24.9
25.7
—
10
63
(3021589) Normoblasts [#/volume] in Blood
53
611
0.80
0.62
7.9
9.0
e9/l
0.0
0.0
0.38
47
501
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
20
0.00
0.61
0.0
2.1
—
15.1
—
0
6
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
52
446
1.25
0.60
1.9
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
18
132
1.41
0.60
3.0
4.6
u/l
231.0
301.5
0.58
18
122
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.60
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
23
0.00
0.59
0.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
23
0.00
0.59
0.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
23
0.00
0.59
0.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
23
0.00
0.59
0.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
139
1333
1.37
0.57
4.9
4.6
mmol/l
1.5
1.6
2.28
127
1215
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
82
1.50
0.56
1.9
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
31
373
0.79
0.52
2.6
2.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
24
190
1.31
0.52
1.4
1.6
s
26.8
29.0
1.62
24
182
(40761536) Microorganisms panel - Urine sediment
7
110
0.62
0.50
2.3
4.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
146
1.34
0.50
1.6
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
37
313
1.24
0.48
2.1
2.4
umol/l
326.1
10017.1
2.51
31
265
(3028026) IgM [Mass/volume] in Serum or Plasma
5
81
0.60
0.47
1.0
1.8
g/l
1.2
1.6
—
5
73
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
31
1.63
0.43
1.2
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
33
1.53
0.41
1.8
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
59
1.37
0.41
1.5
5.0
%
1.5
1.6
—
8
54
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
2.9
—
0
9
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
17
0.00
0.41
0.0
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
7
105
0.65
0.41
1.3
2.6
g/l
9.4
10.2
—
7
97
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
19
0.00
0.39
0.0
2.8
—
2.6
—
0
12
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8
113
0.69
0.38
1.5
1.2
%
1.5
1.3
—
8
100
(3048689) Calprotectin [Mass/mass] in Stool
12
157
0.74
0.38
1.2
1.8
ug/g
50.0
129.1
1.43
12
119
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
90
0.65
0.33
1.2
1.7
—
—
—
0
0
(4035726)
10
132
0.74
0.33
1.4
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
38
336
1.17
0.32
2.3
2.1
mg/l
4.9
3.3
1.70
33
282
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
33
289
1.18
0.31
1.5
1.6
pmol/l
477.2
480.0
0.02
26
233
(40768797) Stomach Pathology biopsy report
23
195
1.21
0.30
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
273
1.17
0.28
1.2
1.3
u/ml
12.3
11.1
0.04
21
101
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
71
0.69
0.26
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
51
469
1.13
0.25
2.7
3.4
ph
7.4
7.4
—
7
85
(3002256) Pathology report gross observation
14
169
0.81
0.25
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
81
0.73
0.25
1.7
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
83
0.71
0.24
1.2
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
58
539
1.12
0.24
2.9
3.2
mmol/l
2.4
2.4
0.45
52
459
(21494755) Public health laboratory ask at order entry panel
6
85
0.69
0.24
1.3
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
61
570
1.11
0.23
13.1
7.7
inr
1.1
1.2
—
10
162
(3000991) Gas panel - Venous blood
11
88
1.27
0.23
1.8
6.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
93
0.74
0.23
1.6
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
145
1.19
0.21
1.3
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
2.5
—
13.5
—
0
11
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
89
1.25
0.21
1.6
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
18.6
—
0
12
(21494890) Protein electrophoresis panel - 24 hour Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
60.3
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
29.1
—
0
8
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
222.0
—
0
8
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
643.1
—
0
8
(4062490)
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
68
717
0.91
0.20
3.9
5.3
e9/l
0.2
0.2
0.08
62
626
(3001122) Ferritin [Mass/volume] in Serum or Plasma
62
585
1.10
0.19
2.2
2.6
ug/l
114.9
90.8
0.57
57
534
(3013707) Erythrocyte sedimentation rate by Westergren method
108
1046
1.10
0.19
4.5
4.4
mm/h
15.6
13.0
0.96
99
949
(3014111) Lactate [Moles/volume] in Serum or Plasma
13
110
1.20
0.18
1.8
5.1
mmol/l
1.2
1.4
0.57
13
105
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
66
0.75
0.17
2.6
5.4
mmol/l
24.6
25.8
—
5
66
(3022145) Colonoscopy Study observation
16
176
0.90
0.10
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
63
1.12
0.08
1.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
204
0.92
0.07
1.6
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
86
1.05
0.07
2.1
2.3
—
—
—
0
0
(3000492) Spirometry study
10
111
0.89
0.06
1.1
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
127
1283
0.95
0.05
7.9
13.1
ml/min/173m2
75.9
77.4
0.32
108
1046
(3017181) Myelocytes/100 leukocytes in Blood
13
120
1.09
0.05
2.6
3.8
%
1.7
1.1
—
6
31
(3037467) Urinalysis macro (dipstick) panel - Urine
98
992
0.97
0.04
4.2
4.7
—
—
—
0
0
(3012544) pH of Venous blood
11
119
0.92
0.04
1.5
3.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
68
690
0.97
0.02
3.9
5.1
e9/l
0.0
0.0
0.79
61
593
(3019225) pH of Specimen
13
138
0.94
0.02
2.2
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
68
688
0.98
0.01
3.9
5.1
e9/l
0.5
0.6
0.79
61
590
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
126
0.95
0.00
2.3
2.0
nmol/l
402.7
373.5
0.48
12
119
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
275
0.98
0.00
1.3
1.3
iu/ml
34.3
41.9
—
9
90
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
215
0.97
0.00
1.7
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
175
1.03
0.00
1.4
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
70
701
1.00
0.00
3.9
5.1
e9/l
1.7
1.9
0.73
64
618
(3001019) Free T4 and TSH panel - Serum or Plasma
5
55
0.91
0.00
2.0
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.0
—
0
5
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.5
—
0
5
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
79.6
—
0
5
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
14.5
—
0
8
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
3.5
—
47.3
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
29.4
—
0
7
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
6
0.00
0.00
0.0
22.5
—
77.7
—
0
6
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
105.9
—
0
9
(44806420)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
72
0.97
0.00
2.1
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
77.5
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
8
0.00
0.00
0.0
2.1
—
10.2
—
0
8
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
30.1
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
9.9
—
0
7
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
1.8
—
0
8
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
5.9
—
0
7
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_ENDOMETRIUM – Carcinoma in situ of endometrium

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).